PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22901187-0	2012	Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict platinum-based chemotherapy response of advanced non-small cell lung cancers in a Chinese population.	Platinum	59-67	AKT serine/threonine kinase 1	Homo sapiens	34-37	
22901187-7	2012	CONCLUSIONS: Our findings suggest that genetic variants in the PI3K/PTEN/AKT/mTOR pathway may predict platinum-based chemotherapy response in advanced NSCLC patients in a Chinese population.	Platinum	102-110	AKT serine/threonine kinase 1	Homo sapiens	73-76